about
Novel Molecular Markers for Breast CancerAberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerMMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancerSignatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancerThe direct effect of focal adhesion kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis.Haploinsufficient tumor suppressor genes.Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform.Critical roles of DMP1 in human epidermal growth factor receptor 2/neu-Arf-p53 signaling and breast cancer development.Dmp1α inhibits HER2/neu-induced mammary tumorigenesis.Transgenic and knockout mice models to reveal the functions of tumor suppressor genes.Signal transduction involving the dmp1 transcription factor and its alteration in human cancerRegulation of murine hematopoietic stem cell quiescence by Dmtf1Hypergrowth mTORC1 signals translationally activate the ARF tumor suppressor checkpoint.MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1.Changes in p19Arf localization accompany apoptotic crisis during pre-B-cell transformation by Abelson murine leukemia virus.Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer.Role of DMP1 and its future in lung cancer diagnostics.Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer.The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesisAberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancerTumor suppressor genes in myeloid differentiation and leukemogenesis.Aberrant expression of cyclin D1 in cancer.Clinical applications of mouse models for breast cancer engaging HER2/neu.Alterations of p63 and p73 in human cancers.Transcription factors that interact with p53 and Mdm2CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation.Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α.Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer.Dmp1 physically interacts with p53 and positively regulates p53's stability, nuclear localization, and function.Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.Repression of Dmp1 and Arf transcription by anthracyclins: critical roles of the NF-kappaB subunit p65.
P2860
Q26753160-DB831432-5DCA-4CF3-BC5C-DE0AA6A18DAFQ26773907-8C4118A4-6E5D-4572-A6D5-3818FC0EA9AFQ28250940-01148067-DFB5-44ED-9BA8-44B82C397016Q28389284-62CD24B7-999A-4C34-8B44-52B97303A1B4Q33492610-3ECA3517-82A9-46FB-8CB4-AF0ECEA5FDAEQ33864922-94ABE863-345D-41A6-AF3D-5A90577018F1Q33903965-94F4FFCD-1011-4921-8F91-767E32B96797Q34048030-ADE8FD6F-8982-4760-B0CF-2552D189A4B2Q34778229-FF0E6AFE-44F8-45F2-A9D1-FDD2342C3997Q35035710-98E16D57-AFC4-4E82-BCF6-3BB1FEE418FBQ35155473-8346BD18-0AC7-4B41-A6CC-9ABFB3A5D019Q35181050-0BCBD039-79A5-4833-A1EC-0B192DB35C13Q35623644-1F03E966-3A98-4E2A-8ED9-166A950248B1Q35665702-A874DC78-293D-4EB9-8921-F0E02B2BA6DEQ36140715-56EB4D77-4D16-46DD-988E-27EA9C90A71BQ36845954-BD8F70A5-F8E7-43BF-981C-34E3594B1878Q37093018-0121B507-32FE-4BF2-AC75-B3C4217B250EQ37111920-17B5F16F-B1CB-4FB5-BC7E-698FA07D618BQ37218223-21C837A7-DC9E-49AE-BECB-AA44DCEAD5FAQ37220014-7344FB06-09DA-4E69-9D0D-ABC14029EB51Q37306546-EA55845D-8FEC-499B-9E8E-2D32D32DD8D0Q37414369-36FC77D9-F0CE-49EE-AE4B-249746AC0BCBQ37580471-55FACD1F-F1E9-4946-A3B6-D92D3DF3401DQ37607675-D26A6984-F167-40A0-8951-135FB96D5E8BQ38247152-8624F69E-6033-4026-A099-38838A5A464EQ38541481-D29EFE2E-4937-47D9-A0F7-E1004C826721Q38616175-AD6CA966-8FE0-494D-ACAE-2BD4D00061BCQ38838490-B73CFCD0-367F-4F4C-B8F4-EF7D2531F0B2Q38935156-83E268BB-1398-43AB-A197-E490E587B1D4Q40067775-1A7361B7-5847-46DE-A610-8A16A7A30F4BQ42246401-70E15738-D648-4A02-A629-DB4750125715Q42708335-DA3F71A3-A19B-42AE-8621-FCD225B820FFQ42734642-43BB9404-1E0D-435A-89E9-3E5C61AB17CA
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Dmp1 and tumor suppression.
@ast
Dmp1 and tumor suppression.
@en
type
label
Dmp1 and tumor suppression.
@ast
Dmp1 and tumor suppression.
@en
prefLabel
Dmp1 and tumor suppression.
@ast
Dmp1 and tumor suppression.
@en
P2093
P2860
P356
P1433
P1476
Dmp1 and tumor suppression.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1210226
P407
P577
2007-01-22T00:00:00Z